Mark Vignola
Director of Finance/CFO at TERNS PHARMACEUTICALS, INC.
Net worth: 571 697 $ as of 2024-03-30
Network origin in Mark Vignola first degree
Entity | Entity type | Industry | |
---|---|---|---|
Boston College
358
| College/University | Other Consumer Services | 358 |
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.
339
| College/University | Other Consumer Services | 339 |
Lehman Brothers, Inc.
Lehman Brothers, Inc. Investment Banks/BrokersFinance A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues.
67
| Extinct | Investment Banks/Brokers | 67 |
Needham & Co. LLC
Needham & Co. LLC Investment Banks/BrokersFinance Needham & Co. LLC (Needham) is a registered investment advisor and broker/dealer headquartered in New York City. The firm was founded in 1985 and is a wholly-owned indirect subsidiary of The Needham Group, Inc. Needham provides corporate and institutional clients with high quality research, corporate access, capital markets and trading execution services in both the public and private markets, with an emphasis on growth companies.
43
| Subsidiary | Investment Banks/Brokers | 43 |
Public Company | Pharmaceuticals: Major | 27 | |
Public Company | Biotechnology | 20 | |
Duke University Medical Center
8
| College/University | Other Consumer Services | 8 |
Public Company | Pharmaceuticals: Major | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Mark Vignola via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
BIOCRYST PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
EBAY INC. | Internet Retail | Corporate Officer/Principal Corporate Officer/Principal | |
OrbiMed Advisors LLC
OrbiMed Advisors LLC Investment ManagersFinance OrbiMed Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. It was founded by Sven Borho and Carl Gordon in 1989. The firm provides discretionary investment management services to US and non-US public and private funds. | Investment Managers | Founder Corporate Officer/Principal | |
Deutsche Bank Securities, Inc.
Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Deutsche Bank Securities, Inc. (DBSI) is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1971 and is a wholly-owned investment banking and brokerage arm of DB U.S. Financial Markets Holding Corp., ultimately held by Deutsche Bank AG (NYSE: DB, FRA: DBK) in Germany. DBSI provides securities brokerage and investment advisory services to domestic and international private clients and institutions. They are also a primary dealer in US government securities as designated by the Federal Reserve. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
Cerexa, Inc.
Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
AVEDRO, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
GELESIS INC | Biotechnology | Director/Board Member Chairman | |
MYOKARDIA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
RHYTHM PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
CENTREXION THERAPEUTICS CORPORATION | Pharmaceuticals: Major | Founder Director/Board Member | |
TURG POIN | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Corporate Officer/Principal | |
University of Pennsylvania | College/University | Masters Business Admin Doctorate Degree Undergraduate Degree | |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Financial Conglomerates | Analyst-Equity Corporate Officer/Principal | |
PACIRA BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Massachusetts Institute of Technology | College/University | Doctorate Degree Masters Business Admin | |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree | |
Rutgers State University of New Jersey | College/University | Undergraduate Degree Masters Business Admin | |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Graduate Degree | |
University of California San Diego | College/University | Doctorate Degree Undergraduate Degree | |
University of Florida | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
RELYPSA INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
ZYNGA INC. | Packaged Software | Director/Board Member Corporate Officer/Principal | |
Allergan GI Corp.
Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Biotechnology | Director/Board Member Chief Executive Officer | |
Tuck School of Business at Dartmouth | College/University | Masters Business Admin Masters Business Admin | |
The University of Chicago Booth School of Business | College/University | Masters Business Admin Masters Business Admin | |
PROTHENA CORPORATION PLC | Biotechnology | Director/Board Member Corporate Officer/Principal | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
SCPHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
PASSAGE BIO, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Chief Operating Officer | |
NightstaRx Ltd.
NightstaRx Ltd. Medical/Nursing ServicesHealth Services NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
NIGHTSTAR THERAPEUTICS PLC | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO General Counsel | |
Intercept Pharma UK & Ireland Ltd.
Intercept Pharma UK & Ireland Ltd. Medical DistributorsDistribution Services Founded in 2015, Intercept Pharma UK & Ireland Ltd. is a pharmaceutical wholesaler. Part of Intercept Pharmaceuticals, Inc., the private company is based in Bristol, UK. | Medical Distributors | Director/Board Member Director/Board Member | |
Attralus, Inc.
Attralus, Inc. Pharmaceuticals: MajorHealth Technology Attralus, Inc. operates as a biopharmaceutical company. The firm focuses on illuminating the systemic nature of amyloidosis and creating transformative medicines to improve the lives of patients. The company was founded by Jonathan Wall in 2019 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Intercept Pharma Deutschland GmbH
Intercept Pharma Deutschland GmbH Medical DistributorsDistribution Services Part of Intercept Pharmaceuticals, Inc., Intercept Pharma Deutschland GmbH is a German company focused on building a healthier tomorrow for patients with progressive non-viral liver diseases. The private company is based in Munich, Germany. The CEOs are Rocco Venezia, Michael Gemellaro, Willem Wouter Van Weperen. The company was founded in 2015. | Medical Distributors | Chief Executive Officer Chief Executive Officer | |
STRUCTURE THERAPEUTICS INC. | Miscellaneous Commercial Services | Chairman Corporate Officer/Principal | |
Adicet Therapeutics, Inc.
Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Excellentia Global Partners
Excellentia Global Partners Financial ConglomeratesFinance Excellentia Global Partners is a life sciences investment bank that works with life science companies, medical device, diagnostic/proteomics companies. The private company is based in New York, NY. The company connects its life science clients with sources of capital in the venture capital and private equity arena. The CEO of the company is Keith M. Gottesdiener. | Financial Conglomerates | Chief Executive Officer |
Statistics
International
United States | 46 |
United Kingdom | 4 |
Ireland | 2 |
Germany | 2 |
Sectoral
Health Technology | 23 |
Consumer Services | 13 |
Finance | 9 |
Commercial Services | 4 |
Distribution Services | 3 |
Operational
Director/Board Member | 400 |
Corporate Officer/Principal | 173 |
Independent Dir/Board Member | 115 |
Undergraduate Degree | 91 |
Chairman | 66 |
Most connected contacts
Insiders | |
---|---|
Carl Gordon | 59 |
Jeffrey Kindler | 47 |
Daniel Bradbury | 45 |
Jonathan Silverstein | 42 |
Ruggero Magnoni | 31 |
Hong Bo Lu | 28 |
Gino Santini | 26 |
William Kane | 26 |
Jake Bauer | 24 |
Daniel Welch | 24 |
Barbara Duncan | 22 |
Gregory Grunberg | 20 |
Sandipkumar S. Kapadia | 19 |
Klaus Veitinger | 18 |
Wesley Barton | 16 |
- Stock Market
- Insiders
- Mark Vignola
- Company connections